ABSTRACT
Myopia represents a widespread global public health concern influenced by a combination of environmental and genetic factors. The prevailing theory explaining myopia development revolves around scleral extracellular matrix (ECM) remodeling, characterized by diminished Type I collagen (Col-1) synthesis and increased degradation, resulting in scleral thinning and eye axis elongation. Existing studies underscore the pivotal role of scleral hypoxia in myopic scleral remodeling. This study investigates the peroxidase-like activity and catalytic performance of octahedral Palladium (Pd) nanocrystals, recognized as nanozymes with antioxidative properties. We explore their potential in reducing oxidative stress and alleviating hypoxia in human scleral fibroblasts (HSF) and examine the associated molecular mechanisms. Our results demonstrate the significant peroxidase-like activity of Pd nanocrystals. Furthermore, we observe a substantial reduction in oxidative stress in HSF under hypoxia, mitigating cellular damage. These effects are linked to alterations in Nrf-2/Ho-1 expression, a pathway associated with hypoxic stress. Importantly, our findings indicate that Pd nanocrystals contribute to attenuated scleral matrix remodeling in myopic guinea pigs, effectively slowing myopia progression. This supports the hypothesis that Pd nanocrystals regulate myopia development by controlling oxidative stress associated with hypoxia. Based on these results, we propose that Pd nanocrystals represent a novel and potential treatment avenue for myopia through the modulation of scleral matrix remodeling. This study introduces innovative ideas and directions for the treatment and prevention of myopia.
Subject(s)
Extracellular Matrix , Heme Oxygenase-1 , Myopia , NF-E2-Related Factor 2 , Nanoparticles , Palladium , Sclera , Signal Transduction , Animals , NF-E2-Related Factor 2/metabolism , Extracellular Matrix/metabolism , Extracellular Matrix/drug effects , Sclera/metabolism , Humans , Palladium/chemistry , Nanoparticles/chemistry , Nanoparticles/administration & dosage , Signal Transduction/drug effects , Myopia/metabolism , Heme Oxygenase-1/metabolism , Guinea Pigs , Fibroblasts/metabolism , Fibroblasts/drug effects , Oxidative Stress/drug effects , Male , Hypoxia/metabolism , Disease Progression , Cells, CulturedABSTRACT
Microplastics in wastewater have been investigated globally, but less research on the migration and transformation of microplastics throughout wastewater and sludge treatment. This study investigated the fate of microplastics in a reclaimed wastewater treatment plant and a centralized sludge treatment center with thermal hydrolysis and anaerobic digestion. The results exhibited that the effluent microplastics of this reclaimed wastewater treatment plant were 0.75 ± 0.26 items/L. Approximately 98 % of microplastics were adsorbed and precipitated into sludge. After thermal hydrolysis, anaerobic digestion and plate and frame dewatering, the removal rate of microplastics was 41 %. Thermal hydrolysis was the most effective method for removing microplastics. Polypropylene, polyamide and polyethylene were widely detected in wastewater and sludge. 30 million microplastics were released into the downstream river and 51.80 billion microplastics entered soil through sludge cake daily. Therefore, substantial microplastics still entered the natural environment despite the high microplastics removal rate of reclaimed wastewater and sludge treatment.